Zealand Pharma
Clinical trials sponsored by Zealand Pharma, explained in plain language.
-
Could a weekly shot free short bowel patients from IV bags?
Disease control Recruiting nowThis phase 3 trial tests glepaglutide, a synthetic hormone given as a twice-weekly injection, in 90 adults with short bowel syndrome who rely on IV nutrition. The goal is to see if the drug can safely reduce the amount of IV support needed. Participants will be randomly assigned …
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug ZP9830 enters first human safety study
Knowledge-focused Recruiting nowThis early-stage trial tests the safety and tolerability of a new drug called ZP9830 in 124 healthy adults aged 18-45. Participants receive either the drug or a placebo, given as an injection under the skin or into a vein. The study aims to understand how the drug behaves in the …
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC